Back
DFA Dimensional World ex US Core Equity 2 ETF Vs. CRISPR Therapeutics AG Industry Stock Comparison
Buy
73
DFAX
DFA Dimensional World ex US Core Equity 2 ETF
Last Price:
$32.38
Seasonality Move:
9.64%
Sell
43
CRSP
CRISPR Therapeutics AG
Last Price:
$55.85
Seasonality Move:
14.46%
Buy
73
DFA Dimensional World ex US Core Equity 2 ETF (DFAX)
is a Buy
Is DFA Dimensional World ex US Core Equity 2 ETF a Buy, Sell or Hold?
-
The current DFA Dimensional World ex US Core Equity 2 ETF [DFAX] share price is $32.38. The Score for DFAX is 73, which is 46% above its historic median score of 50, and infers lower risk than normal.
-
DFAX is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
43
CRISPR Therapeutics AG (CRSP)
is a Sell
Is CRISPR Therapeutics AG a Buy, Sell or Hold?
-
The current CRISPR Therapeutics AG [CRSP] share price is $55.86. The Score for CRSP is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
-
CRSP is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
DFAX Stock Price Chart
What is DFA Dimensional World ex US Core Equity 2 ETF's stock price today?
-
The DFA Dimensional World ex US Core Equity 2 ETF share price today is $32.38Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and DFAX is experiencing slight selling pressure.
CRSP Stock Price Chart
What is CRISPR Therapeutics AG's stock price today?
-
The CRISPR Therapeutics AG share price today is $55.86The current trend is relatively stagnant and CRSP is experiencing slight buying pressure.
DFAX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.15 | Buy |
| Relative Strength Index (14 RSI): | 56.77 | Buy |
| Chaikin Money Flow: | -111605 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (31.49 - 32.41) | Buy |
| Bollinger Bands (100): | (30.6 - 32.06) | Buy |
CRSP Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.28 | Sell |
| Relative Strength Index (14 RSI): | 49.16 | Sell |
| Chaikin Money Flow: | 78181 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (51.94 - 57.06) | Buy |
| Bollinger Bands (100): | (52.44 - 65.4) | Sell |
DFAX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 32.31 | Buy |
| 20-day SMA: | 32.09 | Buy |
| 50-day SMA: | 31.82 | Buy |
| 200-day SMA: | 29.58 | Buy |
| 8-day EMA: | 32.24 | Buy |
| 20-day EMA: | 32.12 | Buy |
| 50-day EMA: | 31.81 | Buy |
| 200-day EMA: | 29.94 | Buy |
CRSP Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 56.25 | Sell |
| 20-day SMA: | 55.05 | Buy |
| 50-day SMA: | 58.96 | Sell |
| 200-day SMA: | 51.1 | Buy |
| 8-day EMA: | 55.79 | Buy |
| 20-day EMA: | 55.79 | Buy |
| 50-day EMA: | 56.36 | Sell |
| 200-day EMA: | 37.56 | Buy |
DFA Dimensional World ex US Core Equity 2 ETF Earnings Growth & DFAX Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
CRISPR Therapeutics AG Earnings Growth & CRSP Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.26 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.09 per share, and an increase next year of $1.74 per share.
DFA Dimensional World ex US Core Equity 2 ETF Technical Analysis
| Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
CRISPR Therapeutics AG Technical Analysis
| Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||